Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ITRACONAZOLE Cause Bronchopulmonary aspergillosis? 67 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Bronchopulmonary aspergillosis have been filed in association with ITRACONAZOLE (Itraconazole). This represents 1.7% of all adverse event reports for ITRACONAZOLE.

67
Reports of Bronchopulmonary aspergillosis with ITRACONAZOLE
1.7%
of all ITRACONAZOLE reports
13
Deaths
45
Hospitalizations

How Dangerous Is Bronchopulmonary aspergillosis From ITRACONAZOLE?

Of the 67 reports, 13 (19.4%) resulted in death, 45 (67.2%) required hospitalization, and 10 (14.9%) were considered life-threatening.

Is Bronchopulmonary aspergillosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ITRACONAZOLE. However, 67 reports have been filed with the FAERS database.

What Other Side Effects Does ITRACONAZOLE Cause?

Drug ineffective (560) Drug interaction (418) Off label use (268) Condition aggravated (193) Dyspnoea (188) Nausea (153) Drug resistance (152) Rash (125) Hypertension (117) Diarrhoea (114)

What Other Drugs Cause Bronchopulmonary aspergillosis?

TACROLIMUS (968) PREDNISONE (967) DEXAMETHASONE (854) CYCLOPHOSPHAMIDE (824) METHYLPREDNISOLONE (794) PREDNISOLONE (704) MYCOPHENOLATE MOFETIL (702) RITUXIMAB (606) CYCLOSPORINE (583) METHOTREXATE (553)

Which ITRACONAZOLE Alternatives Have Lower Bronchopulmonary aspergillosis Risk?

ITRACONAZOLE vs ITRACONAZOLE\SODIUM ITRACONAZOLE vs IVABRADINE ITRACONAZOLE vs IVACAFTOR ITRACONAZOLE vs IVACAFTOR\LUMACAFTOR ITRACONAZOLE vs IVACAFTOR\TEZACAFTOR

Related Pages

ITRACONAZOLE Full Profile All Bronchopulmonary aspergillosis Reports All Drugs Causing Bronchopulmonary aspergillosis ITRACONAZOLE Demographics